И. Ю. Нагаев
About
In The Last Decade
И. Ю. Нагаев
9 papers receiving 663 citations
Peers
Comparison fields: 5 of 80
- Molecular Biology 310
- Genetics 294
- Molecular Medicine 244
- Infectious Diseases 166
- Epidemiology 86
Countries citing papers authored by И. Ю. Нагаев
This map shows the geographic impact of И. Ю. Нагаев's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by И. Ю. Нагаев with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites И. Ю. Нагаев more than expected).
Fields of papers citing papers by И. Ю. Нагаев
This network shows the impact of papers produced by И. Ю. Нагаев. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by И. Ю. Нагаев. The network helps show where И. Ю. Нагаев may publish in the future.
Co-authorship network of co-authors of И. Ю. Нагаев
This figure shows the co-authorship network connecting the top 25 collaborators of И. Ю. Нагаев. A scholar is included among the top collaborators of И. Ю. Нагаев based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with И. Ю. Нагаев. И. Ю. Нагаев is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Title | Journal | Authors | Indexed citations |
|---|---|---|---|---|
| 1 | Протеолитический гидролиз противоопухолевого пептида HLDF-6-AA в плазме крови | Биоорганическая химия | Yu. A. Zolotarev, С. И. Шрам et al. | 1 |
| 2 | СИНТЕЗ N-АЦИЛЬНЫХ ПРОИЗВОДНЫХ ПЕПТИДА PRO-GLY-PRO-LEU: ПРОТЕОЛИТИЧЕСКАЯ УСТОЙЧИВОСТЬ IN VITRO И ВЛИЯНИЕ НА КЛЕТКИ МЫШИНЫХ МАКРОФАГОВ RAW264.7, "Доклады Академии наук" | Доклады Академии наук | В. В. Безуглов, Mikhail Akimov et al. | 1 |
| 3 | Сравнение фармакокинетики и метаболизма Pro-Gly-Pro-Leu в крови и мозге крыс при интраназальном и внутривенном введении | Доклады Академии наук | Л. А. Андреева, И. Ю. Нагаев et al. | 2 |
| 4 | Протеолиз простых глипролинов лейцинаминопептидазой, ферментами назальной слизи, мембран мозга и крови крыс | Биоорганическая химия | И. Ю. Нагаев, Л. А. Андреева et al. | 3 |
| 5 | [An experimental substantiation for using the "Semax" neuroprotector in the treatment of optic-nerve diseases]. | PubMed | Н Л Шеремет, Л. А. Андреева et al. | 4 |
| 6 | Biological cost and compensatory evolution in fusidic acid‐resistant Staphylococcus aureus | Molecular Microbiology | И. Ю. Нагаев, Jonas T. Björkman et al. | 209 |
| 7 | Structure of a mutant EF-G reveals domain III and possibly the fusidic acid binding site 1 1Edited by I. A. Wilson | Journal of Molecular Biology | Martin Laurberg, O. Kristensen et al. | 125 |
| 8 | The states, conformational dynamics and fusidic acid resistant mutants of EF-G | Lund University Publications (Lund University) | Anders Liljas, O. Kristensen et al. | 1 |
| 9 | Effects of Environment on Compensatory Mutations to Ameliorate Costs of Antibiotic Resistance | Science | Jonas T. Björkman, И. Ю. Нагаев et al. | 339 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.